Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
67.11 USD | +0.78% | +1.96% | +25.93% |
Financials (USD)
Sales 2024 * | 2.48B | Sales 2025 * | 2.65B | Capitalization | 9.06B |
---|---|---|---|---|---|
Net income 2024 * | 227M | Net income 2025 * | 382M | EV / Sales 2024 * | 3.56 x |
Net cash position 2024 * | 262M | Net cash position 2025 * | 748M | EV / Sales 2025 * | 3.13 x |
P/E ratio 2024 * |
40.4
x | P/E ratio 2025 * |
24
x | Employees | 5,000 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.75% |
Latest transcript on Globus Medical, Inc.
1 day | +0.78% | ||
1 week | +1.96% | ||
1 month | +33.08% | ||
3 months | +23.25% | ||
6 months | +45.86% | ||
Current year | +25.93% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Scavilla
CEO | Chief Executive Officer | 59 | 15-05-03 |
David Davidar
FOU | Founder | 58 | 03-02-28 |
David Paul
FOU | Founder | 57 | 03-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Zarrilli
BRD | Director/Board Member | 62 | 19-04-30 |
Rob Douglas
BRD | Director/Board Member | 64 | 19-12-10 |
James Tobin
BRD | Director/Board Member | 79 | 15-08-27 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.01% | 2 M€ | -.--% | ||
0.99% | 144 M€ | -0.99% | - | |
0.74% | 14 M€ | -5.07% | ||
0.44% | 8 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 67.11 | +0.78% | 977,582 |
24-05-30 | 66.59 | +2.02% | 853,511 |
24-05-29 | 65.27 | -0.34% | 625,992 |
24-05-28 | 65.49 | -0.50% | 577,402 |
24-05-24 | 65.82 | +0.66% | 636,464 |
Delayed Quote Nyse, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.93% | 9.06B | |
-7.16% | 178B | |
-1.23% | 107B | |
-4.86% | 67.04B | |
-4.28% | 47.23B | |
+10.32% | 44.62B | |
+8.14% | 42.5B | |
+15.76% | 29.99B | |
+15.53% | 25.22B | |
-5.88% | 24.14B |
- Stock Market
- Equities
- GMED Stock